Product image of Medikinet Mr (Methylphenidate Hydrochloride) supplied by GNH India

Medikinet Mr

Active Ingredient:
Methylphenidate Hydrochloride
Origin:
EU

Medikinet Mr (Methylphenidate Hydrochloride)

Methylphenidate hydrochloride, the active ingredient in Medikinet MR, is a central nervous system stimulant presented as a modified‑release tablet for oral use. It treats attention deficit hyperactivity disorder and narcolepsy in children, adolescents, and adults, helping improve focus and reduce excessive daytime sleepiness.

GNH India supplies Medikinet MR as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide. Our distribution network ensures reliable delivery and compliance with local regulatory requirements. We partner with accredited logistics providers to maintain product integrity.

Manufacturer / TM Owner

Medice Arzneimittel Pütter Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Medikinet MR, a central nervous system stimulant, is used in conditions that involve attention regulation and wakefulness.

  • Attention deficit hyperactivity disorder (ADHD): improves concentration, reduces hyperactivity and impulsivity in children, adolescents and adults
  • Narcolepsy: decreases excessive daytime sleepiness and improves wakefulness

How It Works

  • Methylphenidate hydrochloride acts by inhibiting the reuptake of dopamine and norepinephrine in the central nervous system. By blocking the dopamine transporter (DAT) and norepinephrine transporter (NET), it increases the synaptic concentrations of these neurotransmitters, enhancing neuronal signaling in pathways that regulate attention, impulse control and arousal. The heightened catecholamine activity leads to improved cortical processing and reduced symptoms of inattention and excessive sleepiness.

Side Effects

Methylphenidate may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Insomnia: difficulty falling or staying asleep
  • Decreased appetite: reduced hunger leading to weight loss
  • Headache: mild to moderate head pain
  • Nausea: feeling of sickness or upset stomach

Serious or Rare Side Effects

  • Cardiovascular events: chest pain, hypertension, or arrhythmia
  • Psychosis or severe agitation: hallucinations or extreme anxiety
  • Priapism: prolonged painful erection
  • Severe allergic reaction: rash, swelling, or anaphylaxis

Precautions & Warnings

When prescribing or dispensing Medikinet MR, several safety considerations should be observed.

  • Cardiovascular assessment: evaluate blood pressure and heart history before initiating therapy
  • Psychiatric screening: monitor for pre‑existing psychosis, bipolar disorder, or severe anxiety
  • Growth monitoring: track height and weight in children during long‑term treatment
  • Drug interactions: avoid concurrent use with monoamine oxidase inhibitors
  • Dose adjustments: consider reduced dosing in patients with severe hepatic impairment
  • Store at ambient temperature: keep tablets in the original container, protect from moisture and heat

Avoid Interactions

Methylphenidate can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis or serotonin syndrome
  • Tricyclic antidepressants: may increase cardiovascular side effects
  • Antihypertensive agents: can reduce blood pressure control

Moderate Interactions (Monitor Closely)

  • Selective serotonin reuptake inhibitors (SSRIs): may heighten risk of serotonin syndrome
  • Antacids (aluminum or magnesium): can alter absorption and reduce effectiveness
  • Alcohol: may exacerbate central nervous system stimulation and increase side effects

Frequently Asked Questions

Medikinet MR is a prescription medication indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. In ADHD, it helps improve focus, reduce hyperactivity, and control impulsive behavior. For narcolepsy, it reduces excessive daytime sleepiness and supports better wakefulness.

Methylphenidate increases the levels of dopamine and norepinephrine in the brain by blocking their reuptake transporters. This elevation enhances neurotransmission in pathways that regulate attention, impulse control, and arousal, leading to improved concentration and reduced symptoms of inattention or sleepiness.

The appropriate dose of Medikinet MR is individualized by the prescribing clinician. Factors such as the patient’s age, weight, severity of symptoms, prior response to stimulant therapy, and any co‑existing medical conditions guide the initial dose and any subsequent adjustments.

Safety data for methylphenidate during pregnancy and lactation are limited. Healthcare providers weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss their specific situation with a qualified medical professional before using the product.

To place an order, submit an enquiry on the Medikinet MR product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Medikinet MR is a modified‑release formulation of methylphenidate, offering once‑daily dosing and smoother plasma concentrations compared with immediate‑release methylphenidate. Compared with amphetamine‑based stimulants, it has a different pharmacologic profile and may be preferred when patients experience intolerable side effects from amphetamines or require a specific release pattern.

Store Medikinet MR tablets at ambient temperature, below 25 °C (77 °F). Keep them in the original blister pack or container, protect from moisture, direct sunlight and excessive heat to maintain product stability throughout its shelf life.

Medikinet MR is taken orally, usually once daily in the morning. The tablet should be swallowed whole with a glass of water and not be chewed, crushed, or split, as altering the tablet can affect the intended modified‑release characteristics.

Serious risks include cardiovascular events such as hypertension, chest pain, or arrhythmias, and psychiatric effects like new or worsening psychosis, severe agitation, or mania. Any sudden chest discomfort, severe mood changes, or unusual behavior should prompt immediate medical evaluation.

Medikinet MR is contraindicated in individuals with known hypersensitivity to methylphenidate or any tablet excipients, those taking monoamine oxidase inhibitors (MAOIs) within the past 14 days, and patients with severe cardiovascular disorders, uncontrolled hypertension, or a history of psychosis that is not well managed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methylphenidate Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT